Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9600987 | Clinical Oncology | 2005 | 9 Pages |
Abstract
Now that improvements in outcome from combination treatments, including radiotherapy for pelvic cancer, are being achieved, it is time that serious attention is paid to determining how frequently significant gastrointestinal toxicity arises, and how best to optimise the quality of life of long-term survivors.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Putta, H.J.N. Andreyev,